These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15720106)

  • 1. Use of hyaluronic acid for soft tissue augmentation of HIV-associated facial lipodystrophy.
    Gooderham M; Solish N
    Dermatol Surg; 2005 Jan; 31(1):104-8. PubMed ID: 15720106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyaluronic acid new formulation: experience in HIV-associated facial lipoatrophy.
    Bechara FG; Gambichler T; Brockmeyer NH; Sand M; Altmeyer P; Hoffmann K
    Dermatology; 2008; 217(3):244-9. PubMed ID: 18663308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Efficacy of a Volumizing Hyaluronic Acid Filler for Treatment of HIV-Associated Facial Lipoatrophy.
    Ho D; Jagdeo J
    JAMA Dermatol; 2017 Jan; 153(1):61-65. PubMed ID: 27806168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-density hyaluronic acid for the treatment of HIV-related facial lipoatrophy.
    Pignatti M; Pedone A; Baccarani A; Guaraldi G; Orlando G; Lombardi M; De Santis G
    Aesthetic Plast Surg; 2012 Feb; 36(1):180-5. PubMed ID: 21717261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient Reported Outcomes from HIV Facial Lipoatrophy Treatment With a Volumizing Hyaluronic Acid Filler: A Prospective, Open-Label, Phase I and II Study.
    Ho D; Jagdeo J
    J Drugs Dermatol; 2016 Sep; 15(9):1064-9. PubMed ID: 27602967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large particle hyaluronic acid for the treatment of facial lipoatrophy in HIV-positive patients: 3-year follow-up study.
    Skeie L; Bugge H; Negaard A; Bergersen BM
    HIV Med; 2010 Mar; 11(3):170-7. PubMed ID: 19780861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of one-step rehabilitation of human immunodeficiency virus-related facial lipoatrophy using an injectable calcium hydroxylapatite dermal filler.
    Rauso R; Curinga G; Rusciani A; Colella G; Amore R; Tartaro G
    Dermatol Surg; 2013 Dec; 39(12):1887-94. PubMed ID: 24299576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Porcine filler for facial lipoatrophy associated with human immunodeficiency virus treatment.
    Reytan N; Rzany B
    J Drugs Dermatol; 2008 Sep; 7(9):884-6. PubMed ID: 19112805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A ribose-crosslinked collagen filler treatment for facial lipoatrophy associated with the treatment of human immunodeficiency virus.
    Reytan N; Rzany B
    J Drugs Dermatol; 2008 Dec; 7(12):1169-71. PubMed ID: 19137772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Correction of Iatrogenic Lipoatrophy With Volumizing Hyaluronic Acid Filler.
    Hausauer AK; Jones DH
    Dermatol Surg; 2018 Nov; 44 Suppl 1():S60-S62. PubMed ID: 30359336
    [No Abstract]   [Full Text] [Related]  

  • 11. Retreatment with injectable poly-l-lactic acid for HIV-associated facial lipoatrophy: 24-month extension of the Blue Pacific study.
    Mest DR; Humble GM
    Dermatol Surg; 2009 Feb; 35 Suppl 1():350-9. PubMed ID: 19207325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of polylactic acid implants to correct facial lipoatrophy in human immunodeficiency virus 1-positive individuals receiving combination antiretroviral therapy.
    Cattelan AM; Bauer U; Trevenzoli M; Sasset L; Campostrini S; Facchin C; Pagiaro E; Gerzeli S; Cadrobbi P; Chiarelli A
    Arch Dermatol; 2006 Mar; 142(3):329-34. PubMed ID: 16549708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of lipoatrophy and aging: volume deficits in the face.
    Coleman S; Saboeiro A; Sengelmann R
    Aesthetic Plast Surg; 2009 Jan; 33(1):14-21. PubMed ID: 18987910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the safety and efficacy of poly-L-lactic acid for the treatment of HIV-associated facial lipoatrophy.
    Burgess CM; Quiroga RM
    J Am Acad Dermatol; 2005 Feb; 52(2):233-9. PubMed ID: 15692467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyaluronic Acid Filler in HIV-Associated Facial Lipoatrophy: Evaluation of Tissue Distribution and Morphology with MRI.
    Becker M; Balagué N; Montet X; Calmy A; Salomon D; Toutous-Trellu L;
    Dermatology; 2015; 230(4):367-74. PubMed ID: 25870932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infectious complications of Bio-Alcamid filler used for HIV-related facial lipoatrophy.
    Nadarajah JT; Collins M; Raboud J; Su D; Rao K; Loutfy MR; Walmsley S
    Clin Infect Dis; 2012 Dec; 55(11):1568-74. PubMed ID: 22942210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monophasic, cohesive-polydensified-matrix crosslinking-technology-based hyaluronic acid filler for the treatment of facial lipoatrophy in HIV-infected patients.
    Pavicic T; Ruzicka T; Korting HC; Gauglitz G
    J Drugs Dermatol; 2010 Jun; 9(6):690-5. PubMed ID: 20645533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective, open-label, 18-month trial of calcium hydroxylapatite (Radiesse) for facial soft-tissue augmentation in patients with human immunodeficiency virus-associated lipoatrophy: one-year durability.
    Silvers SL; Eviatar JA; Echavez MI; Pappas AL
    Plast Reconstr Surg; 2006 Sep; 118(3 Suppl):34S-45S. PubMed ID: 16936543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Human Immunodeficiency Virus-Associated Facial Lipoatrophy With Hyaluronic Acid Filler Mixed With Micronized Cross-Linked Acellular Dermal Matrix.
    Kim J; Song SY; Lee SG; Choi S; Lee YI; Choi JY; Lee JH
    J Korean Med Sci; 2022 Feb; 37(5):e37. PubMed ID: 35132843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Polylactic acid injections: usefullness for the treatment of facial lipoatrophy in HIV+ patients under tritherapy].
    Piquet M; Brignol L; Chatelain B; Rey D; Ricbourg B; Meyer C
    Rev Stomatol Chir Maxillofac; 2007 Dec; 108(6):496-504. PubMed ID: 17675198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.